Label-Free Chemiresistive Biosensor for Breast Cancer Specific Point Mutation Detection in BRCA-1 Gene
IEEE Sensors Letters · 2026-09 · 10 (9) · 4503404-4503404
DOI: 10.1109/lsens.2026.3717841 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Sensors Letters, 2026-09. Verfasst von Dharmendra Singh und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Breast cancer remains the most prevalent malignancy among women worldwide, with incidence rates continuing to rise due to multiple genetic and environmental factors. Among these, the 185delAG mutation in the breast cancer gene 1 (BRCA1) gene is strongly associated with impaired deoxyribonucleic acid (DNA) repair mechanisms and increased cancer susceptibility. In this study, a label-free chemiresistive biosensor platform is presented for the detection of the BRCA1 185delAG mutation. The proposed sensor employs conductive solid and hollow polyaniline nanofibers as the sensing layer, forming a conductive bridge across gold interdigitated electrodes. Surface immobilization of 5’ NH2-modified single stranded probe DNA is achieved via glutaraldehyde as crosslinker on PANi nanofibers, enabling selective hybridization with complementary target DNA sequences. The sensing mechanism is based on changes in electrical resistance arising from negative charge accumulation on the PANi matrix upon DNA hybridization, which modulates the conductivity of the nanofiber network. Sensor performance is evaluated by monitoring the change in resistance (ΔR) upon target hybridization, as a function of the target dose (1 pM–0.01 μM). Comparative analysis reveals that hollow PANi nanofibers exhibit higher sensitivity than solid nanofibers, attributed to enhanced surface accessibility and charge interaction. Specificity studies conducted using complementary (C26), mismatched (M26), and nontarget Blank phosphate-buffered saline (PBS) samples confirm the sensor’s ability to discriminate specific mutations with high fidelity. The developed platform offers a rapid, cost-effective, and portable solution for genetic mutation detection, highlighting its potential for integration into point-of-care diagnostic applications.
Zitieren
APA
Singh, D., Sharma, M., Das, B., & Tripathy, S. (2026). Label-Free Chemiresistive Biosensor for Breast Cancer Specific Point Mutation Detection in BRCA-1 Gene. IEEE Sensors Letters, 10(9), 4503404-4503404. https://doi.org/10.1109/lsens.2026.3717841
Vancouver
Singh D, Sharma M, Das B, Tripathy S. Label-Free Chemiresistive Biosensor for Breast Cancer Specific Point Mutation Detection in BRCA-1 Gene. IEEE Sensors Letters. 2026;10(9):4503404-4503404. doi:10.1109/lsens.2026.3717841
BibTeX
@article{Singh2026,
author = {Singh, Dharmendra and Sharma, Muskan and Das, Bodhisatwa and Tripathy, Suryasnata},
title = {Label-Free Chemiresistive Biosensor for Breast Cancer Specific Point Mutation Detection in BRCA-1 Gene},
journal = {IEEE Sensors Letters},
year = {2026},
volume = {10},
number = {9},
pages = {4503404--4503404},
doi = {10.1109/lsens.2026.3717841}
}
EUVIMED